Patent analysis in the Supreme Court - Warner-Lambert v Generics

Last week the Supreme Court gave its decision in a long-running pharmaceutical patent dispute between Warner-Lambert and Generics. The court analysed patent insufficiency as a basis for invalidity and the infringement of Swiss-form claims.

Although most relevant to the drugs industry, this ruling will also be of interest to other patent-heavy sectors. 

We discuss the analysis of insufficiency, and infringement on our sister blog Life Science Law.

Our content explained

Every piece of content we create is correct on the date it’s published but please don’t rely on it as legal advice. If you’d like to speak to us about your own legal requirements, please contact one of our expert lawyers.

Posted by


Mills & Reeve Sites navigation
A tabbed collection of Mills & Reeve sites.
My Mills & Reeve navigation
Subscribe to, or manage your My Mills & Reeve account.
My M&R


Register for My M&R to stay up-to-date with legal news and events, create brochures and bookmark pages.

Existing clients

Log in to your client extranet for free matter information, know-how and documents.


Mills & Reeve system for employees.